We are live on ! Find out more
MURA icon

Mural Oncology

Delisted

MURA was delisted on the 4th of December, 2025.

70 hedge funds and large institutions have $10.6M invested in Mural Oncology in 2025 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 15 increasing their positions, 24 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

278% more call options, than puts

Call options by funds: $185K | Put options by funds: $49K

6.23% less ownership

Funds ownership: 54.96% → 48.73% (-6.2%)

9% less funds holding

Funds holding: 77 → 70 (-7)

38% less repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 24

40% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 15

53% less capital inflows, than outflows

Capital inflows: $2.32M | Capital outflows: $4.97M

Holders
70
Holders Change
-7
Holders Change %
-9.09%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
15
Reduced
24
Closed
15
Calls
$185​K
Puts
$49​K
Net Calls
+$136​K
Net Calls Change
+$247​K

MURA Hedge Fund Activity: Q1 2025 in Review

70 of the 7,493 institutional investors tracked by Wall St. Rank reported a position in Mural Oncology (MURA) for Q1 2025, worth a combined $10.6M — down 65% from $30.2M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of MURA and 9 opened new positions — a net loss of 6 holders — while 24 trimmed existing stakes and 15 added.

The largest buyer was Royal Bank of Canada, adding an estimated $583K. The largest seller was Solas Capital Management, cutting an estimated $1.39M.

  • 70 institutional investors held Mural Oncology (MURA) as of Q1 2025, down from 77 in Q4 2024.
  • Funds reported $10.6M of Mural Oncology stock for Q1 2025, down 65% quarter-over-quarter.
  • 9 funds opened new Mural Oncology positions in Q1 2025 and 15 closed out, a net change of -6 holders.
  • The largest Mural Oncology buyer in Q1 2025 was Royal Bank of Canada, an estimated $583K added.
  • The largest Mural Oncology seller in Q1 2025 was Solas Capital Management, an estimated $1.39M sold.

Based on aggregated 13F filings for Q1 2025.